Literature DB >> 18515282

Recent advances in the natural history of hepatocellular carcinoma.

F Trevisani1, M C Cantarini, J R Wands, M Bernardi.   

Abstract

Ongoing advances in liver disease management and basic research in recent years have changed our knowledge of the natural history of hepatocellular carcinoma (HCC). Indeed, the natural history of this tumor is fairly long and covers a preclinical and a clinical phase. Some of the biological steps involved in cell transformation and different carcinogenic pathways have been identified, disclosing potential novel markers for HCC. Following the progress in surveillance and early diagnosis, much more is now known about precancerous lesions and the process leading to overt HCC, including growth patterns, dedifferentiation and neoangiogenenesis. In particular, research has focused on clinical and biological factors predicting tumor aggressiveness and patients' prognosis. Lastly, clinical studies have described tumor presentation, evolution and causes of patients' death and how the new knowledge has influenced clinical management and patients' survival in recent years. By addressing 10 key questions, this review will summarize well-established and novel features of the natural history of HCC.

Entities:  

Mesh:

Year:  2008        PMID: 18515282     DOI: 10.1093/carcin/bgn113

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  52 in total

Review 1.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

2.  Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree.

Authors:  Annarita Pecchi; Giulia Besutti; Mario De Santis; Cinzia Del Giovane; Sofia Nosseir; Giuseppe Tarantino; Fabrizio Di Benedetto; Pietro Torricelli
Journal:  World J Hepatol       Date:  2015-02-27

3.  Hepatic tight junctions: from viral entry to cancer metastasis.

Authors:  Nikki P Lee; John M Luk
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

4.  Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma.

Authors:  Yoshito Tomimaru; Hironori Koga; Hirohisa Yano; Suzanne de la Monte; Jack R Wands; Miran Kim
Journal:  Liver Int       Date:  2013-05-08       Impact factor: 5.828

5.  Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.

Authors:  Guang-Zhi Wang; Wei Zhang; Zhu-Ting Fang; Wen Zhang; Min-Jie Yang; Guo-Wei Yang; Shuo Li; Lian Zhu; Li-Li Wang; Wei-Sheng Zhang; Rong Liu; Sheng Qian; Jian-Hua Wang; Xu-Dong Qu
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-23       Impact factor: 4.553

6.  A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma.

Authors:  Masato Fujii; Yuichiro Shibazaki; Kyoko Wakamatsu; Yutaka Honda; Yusuke Kawauchi; Kenji Suzuki; Somasundaram Arumugam; Kenichi Watanabe; Takafumi Ichida; Hitoshi Asakura; Hiroyuki Yoneyama
Journal:  Med Mol Morphol       Date:  2013-02-22       Impact factor: 2.309

Review 7.  Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.

Authors:  Carmen Berasain; María Elizalde; Raquel Urtasun; Josefa Castillo; Oihane García-Irigoyen; Iker Uriarte; Maria U Latasa; Jesús Prieto; Matías A Avila
Journal:  Hepat Oncol       Date:  2014-03-20

8.  Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis.

Authors:  D Heim; K Cornils; K Schulze; B Fehse; A W Lohse; T H Brümmendorf; H Wege
Journal:  Oncogene       Date:  2014-01-13       Impact factor: 9.867

Review 9.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

10.  Grp78 promotes the invasion of hepatocellular carcinoma.

Authors:  Rongjian Su; Zhen Li; Hongdan Li; Huijuan Song; Cuifen Bao; Jia Wei; Liufang Cheng
Journal:  BMC Cancer       Date:  2010-01-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.